Silencing STAT3 and HIF-1α leads to an increase in the concentration of macrophages (CD11b+ cells) and M1 macrophages that infiltrate the tumor microenvironment (CD169+ cells). It also leads to the reversal of the tumor-promoting function of TAMs-mainly angiogenesis and tumor cell activation. The gene discussed is SIGLEC1; the disease is neoplasm.